JAK Inhibition in Food Allergy

NCT05069831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Food Allergy

Interventions

DRUG: Abrocitinib

Sponsor

Icahn School of Medicine at Mount Sinai